Egon Zehnder
Suche
Select region
Close filter

Moses Zonana

Kontakt

+305 569 1014

Moses Zonana draws on his experience in MedTech, digital health, telecom and technology to help clients across a range of industries tackle complex transformation, leadership, and organizational challenges. He is active in Egon Zehnder’s Healthcare and Technology Communications Practices, and he is particularly energized by building resilient, adaptable, cohesive, and purpose-driven teams.

Sustainable organizational success is about people, processes, product, and purpose. I am privileged to work with industry leaders to funnel the right talent to the right leadership roles and contextual purpose to harness the full potential of people.

Before joining the Firm, Moses was an entrepreneur, founding and running several start-ups, including Compliance Meds Technologies, Reliance Meds, TLeMAZ and NetLogistiK.

He earned an MBA from Harvard University and a BA from Rutgers University. Moses is active in Angel Investment Groups and was a member of the Entrepreneurs Organization (South Florida Chapter) for more than 10 years. Outside of work, Moses is an avid squash and tennis player.

Kontakt
E-Mail an Moses Zonana
Alles durchsuchen
Interviews, Artikel und Studien

Weltweite Experten

Paul Havranek

Paul Havranek

London

Based in London, Paul Havranek leads the Infrastructure segment of Egon Zehnder’s global Financial Services and Industrial practices. He guides… Mehr erfahren

Xuemei Bennink-Bai

Xuemei Bennink-Bai

Shanghai

Xuemei Bennink-Bai is a Partner and trusted advisor to global and Chinese clients. She specializes in top executive succession, leadership… Mehr erfahren

Maitée Camargo

Maitée Camargo

São Paulo

Maitée Soares de Camargo advises health and agribusiness clients on CEO succession, management team assessment, leadership development… Mehr erfahren

Changing language

Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top